Jacek Olczak

Olczak states that 40% of Philip Morris International's revenue is now "smoke-free" (IQOS and Zyn). He projects Zyn shipments to more than double from 421 million cans in 2023 to over 1 billion in 2026. The market historically discounts tobacco for terminal decline in combustibles. However, PM is successfully transitioning to a growth multiple business (Oral Nicotine/Heat-not-Burn). If Zyn volumes double, revenue quality improves, warranting a re-rating from "value trap" to "growth staple." Long PM as the clear winner in the nicotine transition, specifically for its ownership of Zyn (US growth engine) and IQOS (International scale). Regulatory crackdowns on flavored pouches; potential long-term health studies linking pouches to cardiovascular issues.